Alexandre Theocharides

Alexandre Theocharides

UNVERIFIED PROFILE

Are you Alexandre Theocharides?   Register this Author

Register author
Alexandre Theocharides

Alexandre Theocharides

Publications by authors named "Alexandre Theocharides"

Are you Alexandre Theocharides?   Register this Author

20Publications

357Reads

12Profile Views

Sensitive Quantitative Proteomics of Human Hematopoietic Stem and Progenitor Cells by Data-independent Acquisition Mass Spectrometry.

Mol Cell Proteomics 2019 07 11;18(7):1454-1467. Epub 2019 Apr 11.

From the ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.TIR119.001431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601215PMC
July 2019

Finally: development of humanized lymph nodes.

Nat Methods 2018 08;15(8):580-582

Department of Medical Oncology and Hematology, Division of Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41592-018-0080-5DOI Listing
August 2018

Humanised mouse models for haematopoiesis and infectious diseases.

Swiss Med Wkly 2017 22;147:w14516. Epub 2017 Oct 22.

Haematology, University Hospital Zurich and University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2017.14516DOI Listing
July 2018

-Induced NETosis Is Independent of Peptidylarginine Deiminase 4.

Front Immunol 2018 9;9:1573. Epub 2018 Jul 9.

Section of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.01573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046457PMC
July 2018

Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease.

Oncotarget 2017 Dec 15;8(63):106333-106341. Epub 2017 Nov 15.

Division of Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739737PMC
December 2017

Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency.

Blood 2016 06 24;127(25):3253-9. Epub 2016 Mar 24.

Division of Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-02-696310DOI Listing
June 2016

Humanized hemato-lymphoid system mice.

Haematologica 2016 Jan;101(1):5-19

Hematology, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.115212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697887PMC
January 2016

Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts.

J Exp Med 2012 Sep 3;209(10):1883-99. Epub 2012 Sep 3.

The Campbell Family Cancer Research Institute, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20120502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457732PMC
September 2012

The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders.

Haematologica 2008 Dec 11;93(12):1890-3. Epub 2008 Sep 11.

Experimental Hematology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://www.haematologica.org/cgi/doi/10.3324/haematol.13074
Publisher Site
http://dx.doi.org/10.3324/haematol.13074DOI Listing
December 2008

Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations.

Blood 2008 Apr 14;111(7):3863-6. Epub 2008 Jan 14.

Department of Research, Experimental Hematology, University Hospital Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-09-111971DOI Listing
April 2008

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.

Blood 2008 Feb 5;111(3):1686-9. Epub 2007 Nov 5.

Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo and University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-07-101576DOI Listing
February 2008

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

Blood 2006 Aug 4;108(4):1377-80. Epub 2006 May 4.

Department of Research, Experimental Hematology, Basel University Hospital, Hebelstrasse 20, 4031 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-11-009605DOI Listing
August 2006

Deliberate removal of T cell help improves virus-neutralizing antibody production.

Nat Immunol 2004 Sep 8;5(9):934-42. Epub 2004 Aug 8.

Institute for Experimental Immunology, University Hospital Zürich, Schmelzbergstrasse 12, CH-8091 Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni1102DOI Listing
September 2004